2023-11-15T09:52:09-06:00 2022-12-31 341884125 CBIZ MHM LLC 4722 N 24TH ST STE 300 PHOENIX AZ 85016 990 2022-01-01 860707697 DONOR NETWORK OF ARIZONA DONO 6022222200 2010 W RIO SALADO PKWY TEMPE AZ 85281 KATHY MILLS SENIOR VICE-PRESIDENT & CFO 6022222200 2023-11-15 1 KATHY MILLS 999009999 1 AMY A O'LOUGHLIN P00869687 6022646835 2023-11-15 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z TIM BROWN 2010 W RIO SALADO PKWY TEMPE AZ 85281 117152252 0 X WWW.DNAZ.ORG X 1992 AZ TO MAKE THE MOST OF LIFE THROUGH THE GIFT OF ORGAN AND TISSUE DONATION AND TO CHALLENGE OURSELVES... TO MAKE THE MOST OF LIFE THROUGH THE GIFT OF ORGAN AND TISSUE DONATION AND TO CHALLENGE OURSELVES AND OTHERS EVERYDAY TO REALIZE ARIZONA'S POTENTIAL TO SAVE AND IMPROVE LIVES. 10 8 296 85 0 0 93230 72548 83117243 90386251 5503526 1202250 28509 34477 88742508 91695526 10000 13000 0 0 26160595 28604042 0 0 0 50768375 55700096 76938970 84317138 11803538 7378388 132834397 108782228 32534045 11609352 100300352 97172876 X TO MAKE THE MOST OF LIFE THROUGH THE GIFT OF ORGAN AND TISSUE DONATION AND TO CHALLANGE OURSELVES AND OTHERS EVERYDAY TO REALIZE ARIZONA'S POTENTIAL TO SAVE AND IMPROVE LIVES. 0 0 61301376 13000 74975915 ORGAN RECOVERY & PLACEMENT SERVICES: DONOR NETWORK OF ARIZONA (DNA) MAXIMIZED THE AVAILABILITY OF HIGH-QUALITY ORGANS AND TISSUES FOR TRANSPLANT AND RESEARCH BY PROVIDING SERVICES TO DONORS, RECIPIENTS, DONOR FAMILIES, DONOR HOSPITALS, AND TRANSPLANT HOSPITALS. IN 2022, DNA SET A RECORD FOR THE HIGHEST NUMBER OF RECOVERED ORGAN DONORS AND ORGANS RECOVERED AND INTENDED FOR TRANSPLANT DNA FACILITATED THE DONATION AND RECOVERY OF 1,083 ORGANS OF WHICH 849 WERE TRANSPLANTED. THESE ORGANS WERE RECOVERED FROM 346 ORGAN DONORS. IN 2022, 459 PEOPLE RECEIVED TRANSPLANTABLE KIDNEYS, 6 PEOPLE RECEIVED KIDNEYS EN BLOC, 93 PEOPLE RECEIVED TRANSPLANTABLE HEARTS, 189 PEOPLE RECEIVED TRANSPLANTABLE LIVERS, 12 PEOPLE RECEIVED TRANSPLANTABLE LIVER SEGMENTS, 28 PEOPLE RECEIVED TRANSPLANTABLE PANCREATA, 4 PEOPLE RECEIVED TRANSPLANTABLE LUNGS, AND 58 PEOPLE RECEIVED TRANSPLANTABLE LUNGS EN BLOC. IN ADDITION, THE ORGANIZATION FACILITATED THE IMPORTATION OF 625 TRANSPLANTABLE ORGANS FROM OTHER GEOGRAPHICAL AREAS. AS DNA CONTINUES TO EXPAND ITS EFFORTS TO IDENTIFY EVERY POSSIBLE OPPORTUNITY TO SAVE LIVES, THE ORGANIZATION IDENTIFIED ANOTHER 141 POTENTIAL ORGAN DONORS FROM WHICH RECOVERY EFFORTS WERE ULTIMATELY UNSUCCESSFUL WHILE ALSO FACILITATING THE RECOVERY OF CLOSE TO 150 ORGANS FOR RESEARCH. NONE OF THESE EFFORTS ARE POSSIBLE WITHOUT THE GENEROSITY OF THE DONORS AND WILLING DONORS IN THE STATE OF ARIZONA AND THESE RECORD NUMBERS ARE A TRIBUTE TO THAT GENEROSITY. 10224355 15410336 TISSUE & OCULAR RECOVERY & PLACEMENT SERVICES: THE ORGANIZATION ALSO FACILITATED THE DONATION AND RECOVERY OF VARIOUS TISSUES FOR TRANSPLANT PURPOSES.IN 2022, DESPITE THE CONTINUED CHALLENGES DUE TO COVID-19 AND ITS AFTERMATH WHICH RESULTED IN THE DEFERRAL OF DONORS AS WELL AS A DECREASE IN ELECTIVE SURGERIES PERFORMED, 1,293 PEOPLE DONATED BONE, CARDIOVASCULAR, OR SKIN TISSUE. OF THESE, 1,038 PEOPLE DONATED BONE FOR ORTHOPEDIC PURPOSES. AS THE NUMBER ONE RECOVERY AGENCY FOR OUR HEART VALVE RECOVERY PARTNER, WE FACILITATED THE DONATION OF ANOTHER RECORD-SETTING 401 HEART VALVES AFTER SETTING THE PREVIOUS RECORD IN 2021 WITH 394 HEART VALVES PROCURED. HEART VALVES ARE MOST FREQUENTLY TRANSPLANTED IN PEDIATRIC PATIENTS. THERE WERE ALSO 687 SAPHENOUS OR FEMORAL VEINS DONATED IN 2022. THE GENEROSITY OF 922 PEOPLE RESULTED IN DONATED SKIN FOR BURN VICTIMS AND RESTORATIVE PROCEDURES. THE 1,293 DONORS ALSO DONATED OTHER CARDIOVASCULAR AND ORTHOPEDIC TISSUES, INCLUDING TISSUES USED TO DECREASE THE LIKELIHOOD OF REJECTION IN ORGAN RECIPIENTS.IN ADDITION, 745 PEOPLE DONATED CORNEAS THAT RESULTED IN 897 CORNEAL TRANSPLANTS, OF WHICH MANY WERE PROVIDED GRATIS OR AT NOMINAL COST TO PATIENTS WHO COULD OTHERWISE NOT AFFORD A TRANSPLANT. THESE DONORS ALSO DONATED SCLERA FOR TRANSPLANTATION PURPOSES. 4828789 DONOR PROGRAM DEVELOPMENT: DONOR PROGRAM DEVELOPMENT AT DONOR NETWORK OF ARIZONA IS ENCOMPASSED BY TWO DEPARTMENTS, HOSPITAL DONOR PROGRAM DEVELOPMENT AND BUSINESS INTELLIGENCE. HOSPITAL DONOR PROGRAM DEVELOPMENT: HOSPITAL DONOR PROGRAM DEVELOPMENT IS RESPONSIBLE FOR MAXIMIZING THE TOTAL NUMBER OF DONORS RECOVERED FOR TRANSPLANT IN ARIZONA THROUGH THE IMPLEMENTATION OF INDIVIDUALIZED DONOR PROGRAMS BASED ON COMPREHENSIVE HOSPITAL ASSESSMENT, ANALYSIS OF THE DONOR POTENTIAL, THE IMPLEMENTATION OF ONGOING QUALITY PROCESS IMPROVEMENT AND INITIATION AND FOSTERING OF EFFECTIVE RELATIONSHIPS WITHIN THE HEALTHCARE COMMUNITY.DONOR NETWORK OF ARIZONA (DNA) CONTINUES TO UTILIZE THE BEST PRACTICES AS DEFINED BY THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES' BREAKTHROUGH COLLABORATIVES FOR ORGAN DONATION AND TRANSPLANTATION. THIS INCLUDES ACTIVE PARTICIPATION IN REGIONAL AND NATIONAL IMPROVEMENT EFFORTS. THESE EFFORTS CONTINUE TO HELP US MAXIMIZE CONVERSION RATES, DONORS AND THE NUMBER OF ORGANS TRANSPLANTED PER DONOR IN ARIZONA. IN ADDITION TO ONGOING EDUCATION IN ARIZONA HOSPITALS AND HEALTHCARE ORGANIZATIONS, DNA HOLDS AN ALL-HOSPITAL SYMPOSIUM EVERY OTHER YEAR.SOME KEY HIGHLIGHTS FOR 2022 INCLUDE:- IMPLEMENTED EXPANDED CLINICAL TRIGGERS IN ALL ARIZONA HOSPITALS, THE CLINICAL INDICATORS THAT IT IS TIME FOR A HOSPITAL TO REFER A POTENTIAL ORGAN DONOR. - THE EXPANDED CLINICAL TRIGGERS ARE IN RESPONSE TO MEDICAL RECORD REVIEW FINDINGS AND MISSED DONOR TRENDS. ROLL OUT INCLUDED RESEARCH, INTERNAL AND EXTERNAL PILOT PROGRAM, RE-EDUCATION OF HOSPITAL STAFF AND RE-ENGINEERING HOW WE FOLLOW POTENTIAL ORGAN DONORS. - FORMALLY TRAINED HOSPITAL DONOR PROGRAM STAFF TO SEE ACTIVE POTENTIAL ORGAN REFERRALS IN RESPONSE TO INCREASED REFERRAL VOLUME DUE TO NEW CLINICAL TRIGGERS.- DEVELOPED AND IMPLEMENTED A NEW PHYSICIAN WELCOME KIT FOR PHYSICIANS NEW TO LARGE DONOR HOSPITALS TO ENSURE THEY ARE ORIENTED TO ORGAN DONATION IN ARIZONA.- CONTINUED IN PERSON EDUCATION WITH OVER 200 EDUCATION EVENTS AS THERE WAS OPPORTUNITY INCLUDING VIRTUAL CLASSES AND QUARTERLY DONATION AND TRANSPLANTATION WEBINARS. DNA ALSO CONTINUES TO PROVIDE CONTINUING EDUCATION CREDITS THROUGH THE CONTINUING NURSING EDUCATION GROUP (CNEG) FOR THE ADVANCED DONOR NURSE CLASS. BUSINESS INTELLIGENCE: THE BUSINESS INTELLIGENCE DEPARTMENT IS RESPONSIBLE FOR IDENTIFYING, FORMULATING, IMPLEMENTING, AND EVALUATING HIGH-QUALITY, DATA DRIVEN DECISION CAPABILITIES AND PROCESS IMPROVEMENT INITIATIVES IN COLLABORATION WITH OTHER LEADERS AND IN ALIGNMENT WITH DONOR NETWORK OF ARIZONA'S STRATEGIC OBJECTIVES. THIS DEPARTMENT INCLUDES DATA SYSTEMS AND ANALYTICS AND DATA INTELLIGENCE TEAMS WHICH COLLECT AND PRESENT DATA NEEDED FOR OPERATIONAL REQUIREMENTS AND TO PROVIDE FLEXIBLE DATA SOLUTIONS TO MEET ORGANIZATIONAL NEEDS. THIS DEPARTMENT IS ALSO RESPONSIBLE FOR OVERSEEING THE DEATH RECORD REVIEW AND HOSPITAL DEATH REPORT AUDIT PROCESSES, AS WELL AS OVERSEEING ACCESS TO ELECTRONIC MEDICAL RECORD (EMR) SYSTEMS IN ARIZONA HOSPITALS FOR DONOR NETWORK OF ARIZONA STAFF. 2022 HIGHLIGHTS INCLUDE THE FOLLOWING:- DEVELOPED AND IMPLEMENTED THE MULTI-DEPARTMENTAL ONEBOARD.THE ONEBOARD IS A SIGNIFICANT IMPROVEMENT IN THE WAY THAT OUR CLINICAL OPERATIONS FOLLOW ORGAN DONATION REFERRALS. IT ALLOWS FOR DATA AT THE FINGERTIPS OF ON CALL LEADERS AS OPPOSED TO SPREAD THROUGHOUT THE EMR. IT ALLOWS DECISION MAKERS TO PAY ATTENTION TO CASES AS THEY ARE TRIAGED TOWARD POSSIBLE FAMILY CONVERSATIONS.- CREATION OF A NEW EXCEPTION REPORTING FRAMEWORK CALL REDBOARD.THE REDBOARD ALLOWS ALL DEPARTMENTS IN REAL-TIME TO BETTER MONITOR AND RESPOND TO INCORRECTLY ENTERED OR INCONGRUENT DATA IN DNA'S EMR.- FULL IMPLEMENTATION OF THE AUTOMATED DEATH RECORD REVIEW PROCESS ON OVER 85% OF HOSPITAL DEATHS.THE NEW HOSPITAL DEATH RECORD AND ICD10 CODE ASSESSMENT SYSTEM IS NOW ESTIMATED TO SAVE APPROXIMATELY 70% OF THE TIME OF THE PREVIOUS MANUAL PROCESS, WHILE ELIMINATING THE VAST MAJORITY OF OPPORTUNITIES FOR USER ERROR.- COMPLETED A RE-WRITE OF THE DATA WAREHOUSE, SUPPORTING ALL NEW REPORTING AT DNA. (CONTINUED) 1056419 HLA LAB 1056419 77410939 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 133 0 1 296 1 0 0 0 0 0 0 0 0 0 0 0 0 X 10 8 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 X KATHY MILLS 6022222200 2010 W RIO SALADO PKWY TEMPE AZ 85281 TIMOTHY BROWN CEO 40.00 X X 594384 0 82771 ROBERT GROSS MD DIRECTOR 2.00 X 30000 0 0 JEREMY GOODMAN MD DIRECTOR 0.30 X 0 0 0 LAWRENCE J KOEP MD DIRECTOR (LEFT 4/22) 0.30 X 0 0 0 BARBARA MCWILLIAMS DIRECTOR 0.30 X 0 0 0 JOHN PETERS DIRECTOR 0.30 X 0 0 0 GREG PIVIROTTO CHAIR 0.30 X X 0 0 0 LAURIE WILSHUSEN DIRECTOR 0.30 X 0 0 0 JOSEPH ZABRAMSKI MD SECRETARY 0.30 X X 0 0 0 DANA JAMISON DIRECTOR 0.30 X 0 0 0 KARIN TOCI DIRECTOR 0.30 X 0 0 0 KATHERINE MILLS SENIOR VICE-PRESIDENT & CF 40.00 X 371310 0 78542 PATRICK J GERAGHTY VICE-PRESIDENT OF CLINICAL 40.00 X 269523 0 66044 SARA PACE JONES VICE-PRESIDENT OF PROGRAM 40.00 X 260381 0 61851 ABDUR RAHMAN HLA ADMINISTRATIVE LAB DIR 40.00 X 222909 0 54063 ALAN TAYLOR DIRECTOR OF TISSUE RECOVER 40.00 X 208778 0 45183 SCOTT WHITELEY DIRECTOR OF IT 40.00 X 201184 0 43980 RICHARD DANIEL MEYERS DIRECTOR OF QUALITY & REGU 40.00 X 178400 0 47670 KATHY KIM DIRECTOR OF FINANCE 40.00 X 179522 0 37183 2516391 0 517287 63 0 1 0 CREATIVE TESTING SOLUTIONS DEPT 880362 PO BOX 29650 PHOENIX AZ 850389650 DONOR TESTING 883904 TRINITY AIR MEDICAL INC 1437 W AUTO DRIVE TEMPE AZ 85284 ORGAN AND TEAM DELIVERIES 880338 ARIZONA TRANSPLANT 2218 N THIRD ST PHOENIX AZ 850041401 SURGICAL ORGAN RECOVERIES 779750 ACQUIRATIS PLC 507 N WESTERN AVE NOGALES AZ 85621 SURGICAL ORGAN RECOVERIES 450250 LEWIS ROCA ROTHBERGER CHIRSTIE LLP PO BOX 51543 LOS ANGELES CA 900515843 LEGAL SERVICES 341478 16 72548 72548 ORGAN PLACEMENT 900099 74975915 74975915 TISSUE PLACEMENT 900099 12461085 12461085 OCULAR PLACEMENT 900099 2949251 2949251 90386251 1150715 1150715 25457069 51192 25312777 143949 144292 -92757 51535 51535 MISCELLANEOUS 900099 34477 34477 34477 91695526 90386251 0 1236727 13000 13000 1598041 1119655 478386 18401519 16405452 1996067 1270023 1243502 26521 5789428 4618958 1170470 1545031 1317742 227289 346993 346993 176815 176815 33147 33147 169114 169114 2034617 1514988 519629 340909 340909 684366 611160 73206 1398372 1048779 349593 631654 512727 118927 211471 162792 48679 508710 168279 340431 293329 234663 58666 1318885 1055108 263777 372511 372511 ORGAN/TISSUE/OCULAR REC 46360744 46360744 HLA LAB EXPENSES 234235 234235 PRINTING & PUBLICATIONS 197432 197432 EQUIPMENT RENTS/MAINT. 177373 174588 2785 209419 43079 166340 84317138 77410939 6906199 0 19112954 19894819 4912854 951368 14667142 16373652 621587 947287 593619 843031 38703497 5760964 33853336 32942533 59067725 36824358 5180 5180 132834397 108782228 8367471 9900345 22246295 0 1920279 1709007 32534045 11609352 X 100300352 97172876 100300352 97172876 132834397 108782228 X 7378388 -10224049 -281815 X 0 1 X 1 0 X 61511 125032 32500 93230 72548 384821 71557015 83489410 78248774 83117243 90386251 406798693 71618526 83614442 78281274 83210473 90458799 407183514 0 0 0 407183514 778922 1069038 952952 1505644 1150715 5457271 778922 1069038 952952 1505644 1150715 5457271 18226 67298 26941 28509 34477 175451 72415674 84750778 79261167 84744626 91643991 412816236 0.98640 0.98640 0.01320 0.01320 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2018 AMOUNT: $ 158. 2020 AMOUNT: $ 26,941. 2021 AMOUNT: $ 28,509. 2022 AMOUNT: $ 34,477. REBATE REWARDS - 2018 AMOUNT: $ 18,068. 2019 AMOUNT: $ 67,298. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 104 1 1 0 1 2513 0 0 1 2956 0 1 27678 33147 0 PART II-B, LINE 1: DONATE LIFE DAY AT THE CAPITOL WAS HELD TO EDUCATE ARIZONA LEGISLATORS ABOUT THE IMPORTANCE OF ORGAN AND TISSUE DONATION. EMPLOYEES AND VOLUNTEERS MET WITH AZ LEGISLATORS AND A LUNCH WAS HELD WITH INFORMATION. MEMBERS OF THE ORGANIZATION ALSO PARTICIPATED IN AOPO ADVOCACY DAY IN WASHINGTON DC TO EDUCATE LEGISLATORS AT THE NATIONAL LEVEL ABOUT ORGAN AND TISSUE DONATION AND DISCUSS RECENT LEGISLATION THAT IMPACTS OUR MISSION. MAILING INVITATIONS TO DLD AT THE CAPITOL. 7278234 7278234 24060155 1439496 22620659 10005 1390 8615 5097817 3538463 1559354 2257286 781615 1475671 32942533 DEFERRED COMPENSATION 1709007 1709007 X 90493276 140256 140256 90353020 1342506 1342506 91695526 84148024 0 84148024 169114 169114 84317138 PART X, LINE 2: DNA QUALIFIES AS A TAX-EXEMPT ORGANIZATION UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (THE "CODE") AND, ACCORDINGLY, THERE IS NO PROVISION FOR INCOME TAXES. DNA IS ALSO EXEMPT FROM STATE INCOME TAX. IN ADDITION, DNA QUALIFIES FOR THE CHARITABLE CONTRIBUTION DEDUCTION UNDER SECTION 170 OF THE CODE AND HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION. INCOME DETERMINED TO BE UNRELATED BUSINESS TAXABLE INCOME ("UBTI") WOULD BE TAXABLE. DNA EVALUATES ITS UNCERTAIN TAX POSITIONS, IF ANY, ON A CONTINUAL BASIS THROUGH REVIEW OF ITS POLICIES AND PROCEDURES, REVIEW OF ITS REGULAR TAX FILINGS, AND DISCUSSIONS WITH OUTSIDE EXPERTS. DNA'S FEDERAL RETURN OF ORGANIZATIONS EXEMPT FROM INCOME TAX (FORM 990) FOR 2019, 2020 AND 2021 ARE SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE, GENERALLY FOR THREE YEARS AFTER THEY WERE FILED. PART XI, LINE 2D - OTHER ADJUSTMENTS: LOSS ON EXTINGUISHMENT OF DEBT 140,256. PART XI, LINE 4B - OTHER ADJUSTMENTS: INTEREST & DIVIDEND INCOME 1,150,715. GAIN/LOSS ON DISPOSAL OF PROPERTY & EQUIPMENT 47,499. GAIN/LOSS ON SALE OF INVESTMENTS 144,292. 1 FOUNDATION FOR BLIND CHILDREN 1234 E NORTHERN AVE PHOENIX AZ 85020 860129981 501(C)(3) 8000 0 PROGRAM SUPPORT 1 PART I, LINE 2: EXECUTIVE LEADERSHIP DETERMINES ELIGIBILITY BASED ON ORGANIZATION'S PURPOSE, INCLUDING WHETHER THERE IS A CORRELATION TO OUR MISSION, VISION, AND CORE VALUES. GRANTS MADE ARE USED FOR THE PURPOSE SPECIFIED, NO ONGOING MONITORING OF THE GRANT FUND IS DEEMED NECESSARY. X X X X X X 0 0 0 0 0 1 0 0 0 TIMOTHY BROWN CEO 554230 0 39392 0 762 0 59594 0 23177 0 677155 0 0 0 KATHERINE MILLS SENIOR VICE-PRESIDENT & CF 344867 0 26185 0 258 0 44373 0 34169 0 449852 0 0 0 PATRICK J GERAGHTY VICE-PRESIDENT OF CLINICAL 250191 0 19194 0 138 0 32202 0 33842 0 335567 0 0 0 SARA PACE JONES VICE-PRESIDENT OF PROGRAM 242118 0 17985 0 278 0 29260 0 32591 0 322232 0 0 0 ABDUR RAHMAN HLA ADMINISTRATIVE LAB DIR 205207 0 17609 0 93 0 22891 0 31172 0 276972 0 0 0 ALAN TAYLOR DIRECTOR OF TISSUE RECOVER 192496 0 15491 0 791 0 22707 0 22476 0 253961 0 0 0 SCOTT WHITELEY DIRECTOR OF IT 185062 0 15864 0 258 0 13389 0 30591 0 245164 0 0 0 RICHARD DANIEL MEYERS DIRECTOR OF QUALITY & REGU 163430 0 14712 0 258 0 26119 0 21551 0 226070 0 0 0 KATHY KIM DIRECTOR OF FINANCE 165221 0 14043 0 258 0 14072 0 23111 0 216705 0 0 0 FORM 990, PART I, LINES 4B AND 6A BONUS PAYMENTS ARE MADE TO ALL EMPLOYEES BASED ON MEETING ORGANIZATIONAL GOALS, HOWEVER, BONUSES FOR ALL EMPLOYEES ARE SUBJECT TO THE ORGANIZATION ACHIEVING 90% OF BUDGETED NET INCOME FOR THE YEAR, UNLESS OTHERWISE VOTED UPON BY THE BOARD OF DIRECTORS. FORM 990, PART III, LINE 4C - PUBLIC EDUCATION HIGHLIGHTS PROGRAMS (CONTINUED) PUBLIC EDUCATION DEPARTMENT: THE FOCUS OF OUR PUBLIC EDUCATION DEPARTMENT IS TO INCREASE ORGAN, EYE AND TISSUE DONOR REGISTRATION IN ARIZONA BY CREATING AND EXPANDING PUBLIC OUTREACH PROGRAMS, DISTRIBUTING INFORMATION, AND DEVELOPING AND EXPANDING COMMUNITY PARTNERSHIPS. SOME KEY PUBLIC EDUCATION HIGHLIGHTS IN 2022 INCLUDE: - MORE THAN 4 MILLION PEOPLE HAVE REGISTERED THEIR DECISION TO BE A DONOR ON THE DONATELIFEAZ REGISTRY. MORE THAN 229,000 JOINED THE REGISTRY IN 2022. - TRANSITIONED BACK TO IN PERSON EVENTS FOLLOWING A HIATUS CAUSED BY THE PANDEMIC. THIS INCLUDED: - INCREASED DONATE LIFE MONTH PARTICIPATION WITH 132 ORGANIZATION PROMOTING THE DONATE LIFE MESSAGE IN APRIL 2022. - DONATE LIFE DAY AT THE D-BACKS, DONATION CELEBRATION AND CELEBRATION OF LIFE TIED UP INTO ONE EVENT, RESULTING IN THE LARGEST D-BACKS GAME ATTENDANCE BY DONATION SUPPORTERS (2,000+ ATTENDED), WITH A DONOR PARADE, FIRST PITCH, MEDIA STORIES ON DONOR HERO, AND TWO SPECIAL AREAS FOR ATTENDEES. - COMPLETED CAMPUS CHALLENGE, WITH 910 NEW REGISTRATIONS (GOAL 745) AMONG 5 UNIVERSITIES (ASU, NAU, PC, OTTAWA, UA) - TARGETED EFFORTS AT ARIZONA DEPARTMENT OF TRANSPORTATION MOTOR VEHICLE DIVISION (ADOT MVD) OFFICES RESULTED IN REGISTRY INCREASES, INCLUDING: - MVD CALL CENTERS DOUBLED THEIR DONOR DESIGNATION RATE (DDR). THE DDR IS THE PERCENTAGE OF PEOPLE WHO CHECK THE BOX TO BE A DONOR OVER THE TOTAL NUMBER OF APPLICATIONS COMPLETED. - 30 OF THE 48 MVD OFFICES INCREASED THEIR DDR COMPARED TO 2021 (BY AN AVG OF 4%). - 11 MVD OFFICES ACHIEVED 40% OR GREATER DDR (COMPARED TO ONLY FOUR IN 2021). - 40 OF THE 62 AUTHORIZED THIRD PARTY (ATP) LOCATIONS INCREASED THEIR DDR COMPARED TO 2021 (BY AN AVG OF 4.4%). - LAUNCHED MVD NEW EMPLOYEE WELCOME KIT AND EDUCATION, WITH NEW HIRES RECEIVING A DONATE LIFE ARIZONA T-SHIRT UPON HIRE AND A DONATE LIFE ARIZONA POLO WITHIN FIRST 90 DAYS. THEY ALSO RECEIVE A PACKET OF PROMO ITEMS AND DONATION INFORMATION. - EARNED 86 EARNED MEDIA STORIES, WITH FOCUS ON MULTICULTURAL STORIES. - WON TWO DONATE LIFE AMERICA PINNACLE AWARDS FOR MARKETING AND PUBLIC RELATIONS ON DONATION. - WE HAD OVER 100 ACTIVE VOLUNTEERS WHO PARTICIPATED IN EVENTS AND ACTIVITIES. OUR VOLUNTEERS CONTINUED ANNUAL VOLUNTEER COMPETENCIES TO DEFINE A SET OF STANDARDS FOR VOLUNTEER KNOWLEDGE AND ENSURE ACCURATE INFORMATION IS BEING COMMUNICATED BY VOLUNTEERS TO POTENTIAL REGISTRANTS. CONTINUED VIRTUAL VOLUNTEER MEETINGS TO ENGAGE VOLUNTEERS, PROVIDE ONGOING EDUCATION, ANSWER QUESTIONS, AND GIVE TIPS. ONBOARDED 21 NEW VOLUNTEERS THROUGH ONLINE TRAINING MODULE. COMMUNICATED IMPORTANT INFORMATION AND DETAILS ON PROGRAMS THROUGH MONTHLY VOLUNTEER E-NEWSLETTER. - WROTE AND DISTRIBUTED EIGHT NEWSLETTERS: - ADOT MVD CONNECTION (2) - HEALTH CARE CONNECTION (2) - EMERGENCY PROFESSIONALS CONNECTION (1) - FUNERAL HOME CONNECTION (2) - YEAR-IN-REVIEW (1) FORM 990, PART VI, SECTION B, LINE 11B THE 990 IS PREPARED BY AN OUTSIDE ACCOUNTING FIRM AND, UPON COMPLETION, A DRAFT IS EMAILED TO ALL MEMBERS OF THE BOARD OF DIRECTORS FOR THEIR REVIEW AND COMMENT. AFTER THEIR REVIEW IS COMPLETE, THE FIRM IS PROVIDED WITH ANY COMMENTS OR CHANGES AND/OR INSTRUCTED TO FILE THE RETURN. FORM 990, PART VI, SECTION B, LINE 12C ALL MEMBERS OF THE DNA BOARD OF DIRECTORS WILL BE REQUIRED TO COMPLETE A CONFLICT OF INTEREST DISCLOSURE STATEMENT UPON AFFILIATION WITH DNA OR HIRING AND TO UPDATE THE STATEMENT AT LEAST ANNUALLY. THE CHIEF EXECUTIVE DIRECTOR SHALL PREPARE A REPORT FOR THE DNA BOARD OF DIRECTORS' ANNUAL MEETING LISTING ALL TRANSACTIONS BETWEEN DNA AND DNA BOARD OF DIRECTORS. THE REPORT WILL INCLUDE: - A DESCRIPTION OF THE TRANSACTION AND ITS DATE. - THE AMOUNT OF THE TRANSACTION AND ITS IMPACT ON DNA. - THE NAME OF THE DNA BOARD OF DIRECTOR MEMBER INVOLVED AND THE NAME OF THE OTHER ENTITY, IF ANY, AND A DESCRIPTION OF THE NATURE OF THE DNA BOARD OF DIRECTOR'S INTEREST IN THE TRANSACTION. IF A CONFLICT OF INTEREST CANNOT BE AVOIDED, THE BOARD MEMBER WHO HAS A CONFLICT OF INTEREST SHALL NOT VOTE ON, PARTICIPATE IN OR ATTEMPT TO INFLUENCE ANY DNA DECISION AFFECTED BY THE CONFLICT OF INTEREST, EXCEPT TO PROVIDE INFORMATION AS SPECIFICALLY REQUESTED BY DECIDING COMMITTEE OR BODY. FORM 990, PART VI, SECTION B, LINE 15 PROCEDURE: COMPENSATION PHILOSOPHY AND STRATEGY THE OBJECTIVES OF DNA'S EXECUTIVE COMPENSATION PROGRAM ARE TO PROVIDE A COMPETITIVE EXECUTIVE TOTAL COMPENSATION PROGRAM COMPARED TO OTHER ORGANIZATIONS OF SIMILAR SIZE AND TYPE, PARTICULARLY HEALTHCARE ORGANIZATIONS. DNA'S PHILOSOPHY IS TO: STRONGLY LINK PAY WITH PERFORMANCE. RETAIN THE TALENTED SENIOR MANAGEMENT TEAM AND DEMONSTRATE THAT DNA VALUES THEM. ENSURE REASONABLE COMPENSATION AS COMPARED TO PEERS. IT IS THE COMMITTEE'S INTENT TO USE PEER DATA FROM SIMILAR POSITIONS IN SIMILAR ORGANIZATIONS UNDER SIMILAR CIRCUMSTANCES. POSITION BASE SALARY COMPETITIVELY AT LEAST AT THE MEDIAN LABOR MARKET AS COMPARED TO PEERS. ENSURE THAT DNA'S TOTAL COMPENSATION, INCLUDING TOTAL CASH COMPENSATION AND EMPLOYEE AND EXECUTIVE BENEFITS, IS POSITIONED AT COMPETITIVE PRACTICE OVERALL WHEN DNA MEETS ITS KEY GOALS. - DNA PROVIDES AN EXECUTIVE COMPENSATION PROGRAM THAT INTEGRATES ALL ELEMENTS OF COMPENSATION AND BENEFITS. - BASE SALARY IS MARKET-BASED AND REFLECTS AN INDIVIDUAL'S PERFORMANCE. ANNUALLY AN INDIVIDUAL'S PERFORMANCE IS EVALUATED RELATIVE TO THEIR POSITION ACCOUNTABILITIES AND PERFORMANCE CRITERIA AS WELL AS ORGANIZATIONAL ACCOUNTABILITIES. - THE ORGANIZATIONAL INCENTIVE PLAN, DNA'S ANNUAL INCENTIVE, REWARDS ACHIEVEMENT ON KEY ORGANIZATIONAL GOALS THAT REPRESENT SUCCESS MEASURES FOR ORGAN PROCUREMENT, EYE AND TISSUE ORGANIZATIONS. INCENTIVE GOALS STRONGLY ALIGN WITH DNA'S MISSION. THE PLAN REWARDS ORGANIZATION-WIDE PERFORMANCE TO REINFORCE TEAMWORK. A THRESHOLD OF FINANCIAL PERFORMANCE IS NECESSARY FOR THE PLAN TO BE AFFORDABLE. PROCEDURE: COMPENSATION COMMITTEE RESPONSIBILITIES AND DUTIES THE COMPENSATION COMMITTEE WILL MEET REGULARLY AS SCHEDULED IN CONJUNCTION WITH BOARD MEETINGS. THE COMPENSATION COMMITTEE WILL BE RESPONSIBLE TO CONTRACT AN OUTSIDE CONSULTANT TO REVIEW AND TREND CURRENT MARKET DATA AND TOTAL EXECUTIVE COMPENSATION TO ENSURE EXECUTIVES ARE REASONABLY COMPENSATED. THIS WILL BE DONE AT A MINIMUM OF TWO TO THREE YEARS OR AS NEEDED. THE COMMITTEE WILL OVERSEE AND SUPERVISE THE CONSULTANT'S WORK PRODUCT. ALL COMPENSATION AGREEMENTS AND DECISIONS MADE BY THE COMMITTEE WILL BE MADE INDEPENDENTLY AND WITH DUE DILIGENCE. ALL COMPENSATION AGREEMENTS AND DECISIONS WILL BE THOROUGHLY DOCUMENTED IN THE FINANCE/COMPENSATION COMMITTEE MINUTES OR THE EXECUTIVE SESSION BOARD MINUTES AS APPROPRIATE. GUIDELINES FOR DOCUMENTATION ARE AS FOLLOWS AND WILL INCLUDE: - IDENTIFICATION OF ATTENDEES - VERIFICATION AND STATEMENT THAT NO MEMBER HAS A CONFLICT OF INTEREST. - DOCUMENTATION THAT THOSE WHO HAVE A CONFLICT WILL BE EXCUSED. - IDENTIFICATION OF SOURCE AND COLLECTION OF COMPENSATION DATA DETAILED DOCUMENTATION OF THE TERMS OF THE COMPENSATION BEING APPROVED IF COMPENSATION VALUE DIFFERS FROM COMPARABILITY DATA, THE BASIS FOR DETERMINATION WILL BE STATED. WITH EACH DECISION REGARDING EXECUTIVE COMPENSATION, THE COMMITTEE WILL BE RESPONSIBLE TO ESTABLISH A "REBUTTABLE PRESUMPTION OF REASONABLENESS". IN DOING SO, THE COMMITTEE WILL: - ENSURE PARTICIPANTS ARE INDEPENDENT - MAKE DECISIONS BASED ON APPROPRIATE COMPARABILITY DATA. - ENSURE MINUTES REFLECT A WRITTEN RECORD OF THE COMMITTEE'S WORK. THE COMPENSATION COMMITTEE WILL REPORT ALL DECISIONS REGARDING EXECUTIVE COMPENSATION TO THE FULL BOARD. THE CEO'S REVIEW AND THE OTHER OFFICERS' REVIEWS WERE PERFORMED DURING QUARTER 3 OF 2022. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S ARTICLES OF INCORPORATION, BY-LAWS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART VI, LINE 5 IN OCTOBER 2021, DNA DETECTED A DATA INCIDENT IN WHICH ATTACKERS ENCRYPTED DATA FROM DNA'S SYSTEMS. UPON LEARNING OF THE INCIDENT, DNA IMMEDIATELY ENGAGED EXTERNAL COUNSEL AND RETAINED A TEAM OF THIRD-PARTY PROFESSIONALS TO INVESTIGATE AND DETERMINE THE FULL SCOPE OF THIS INCIDENT. THE INVESTIGATION WAS COMPLETED WITH NO INDICATION OF ANY MISUSE OF THIS INFORMATION. MANAGEMENT BELIEVES THE MITIGATION EFFORTS ULTIMATELY STRENGTHENED DNA'S NETWORK INFRASTRUCTURE AND SECURITY SIGNIFICANTLY. MANAGEMENT CONTINUES TO MONITOR THE POSSIBLE IMPACTS OF THE INCIDENT ON FUTURE OPERATIONS, AND IT COULD BE POSSIBLE THAT ADDITIONAL LOSSES ARE INCURRED RELATED TO THE INCIDENT. DNA RECORDED APPROXIMATELY $340,000 AND $575,000 OF EXPENSES RELATED TO THIS INCIDENT FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021, RESPECTIVELY, WHICH IS INCLUDED IN INFORMATION TECHNOLOGY EXPENSES. FORM 990, PART XI, LINE 9: CHANGE IN VALUE OF DEFERRED COMPENSATION PLAN -281,815.